Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke

被引:0
|
作者
Jin, Aoming [1 ,2 ]
Wang, Mengxing [1 ,2 ]
Chen, Weiqi [1 ,2 ]
Yan, Hongyi [1 ,2 ]
Xiang, Xianglong [1 ,2 ]
Pan, Yuesong [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
cholesterol efflux capacity; Mendelian randomization; coronary artery disease; stroke; genetics; HIGH-DENSITY-LIPOPROTEIN; MENDELIAN RANDOMIZATION; CARDIOVASCULAR RISK; HDL CHOLESTEROL; EVENTS; ASSOCIATION; INSTRUMENTS; METAANALYSIS; BIAS;
D O I
10.3389/fcvm.2022.891148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundObservational studies indicated that cholesterol efflux capacity (CEC) of high-density lipoprotein (HDL) is inversely associated with cardiovascular events, independently of the HDL cholesterol concentration. The aim of the study is to examine the casual relevance of CEC for coronary artery disease (CAD) and myocardial infarction (MI), and compare it with that for ischemic stroke and its subtypes using a Mendelian randomization approach. MethodsWe performed a 2-sample Mendelian randomization to estimate the casual relationship of CEC with the risk of CAD, MI, and ischemic stroke. A CEC-related genetic variant (rs141622900) and other five genetic variants were used as the instrumental variables. Association of genetic variants with CAD were estimated in a GWAS involving 60,801 CAD cases and 123,504 controls. They were then compared with the associations of these variants with ischemic stroke and its subtypes (large vessel, small vessel, and cardioembolic) involving 40,585 ischemic stroke cases and 406,111 controls. ResultsUsing the SNP of rs141622900 as the instrument, a 1-SD increase in CEC was associated with 45% lower risk for CAD (odds ratio [OR] 0.55, 95% confidence interval [CI] 0.44-0.69, p < 0.001) and 33% lower risk for MI (odds ratio [OR] 0.67, 95% CI 0.52-0.87, p = 0.002). By contrast, the causal effect of CEC was much weaker for ischemic stroke (odds ratio [OR] 0.79, 95% CI 0.64-0.97, p = 0.02; p for heterogeneity = 0.03) and, in particular, for cardioembolic stroke (p for heterogeneity = 0.006) when compared with that for CAD. Results using five genetic variants as the instrument also indicated consistently weaker effects on ischemic stroke than on CAD. ConclusionGenetic predicted higher CEC may be associated with decreased risk of CAD. However, the casual association of CEC with ischemic stroke and specific subtypes would need to be validated in further Mendelian randomization studies.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis
    Wenke Cheng
    Maciej Rosolowski
    Julia Boettner
    Steffen Desch
    Alexander Jobs
    Holger Thiele
    Petra Buettner
    Lipids in Health and Disease, 21
  • [12] Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke
    Hopewell, Jemma C.
    Malik, Rainer
    Valdes-Marquez, Elsa
    Worrall, Bradford B.
    Collins, Rory
    EUROPEAN HEART JOURNAL, 2018, 39 (05) : 354 - +
  • [13] Shared Genetic Susceptibility to Ischemic Stroke and Coronary Artery Disease A Genome-Wide Analysis of Common Variants
    Dichgans, Martin
    Malik, Rainer
    Koenig, Inke R.
    Rosand, Jonathan
    Clarke, Robert
    Gretarsdottir, Solveig
    Thorleifsson, Gudmar
    Mitchell, Braxton D.
    Assimes, Themistocles L.
    Levi, Christopher
    O'Donnell, Christopher J.
    Fornage, Myriam
    Thorsteinsdottir, Unnur
    Psaty, Bruce M.
    Hengstenberg, Christian
    Seshadri, Sudha
    Erdmann, Jeanette
    Bis, Joshua C.
    Peters, Annette
    Boncoraglio, Giorgio B.
    Maerz, Winfried
    Meschia, James F.
    Kathiresan, Sekar
    Ikram, M. Arfan
    McPherson, Ruth
    Stefansson, Kari
    Sudlow, Cathie
    Reilly, Muredach P.
    Thompson, John R.
    Sharma, Pankaj
    Hopewell, Jemma C.
    Chambers, John C.
    Watkins, Hugh
    Rothwell, Peter M.
    Roberts, Robert
    Markus, Hugh S.
    Samani, Nilesh J.
    Farrall, Martin
    Schunkert, Heribert
    STROKE, 2014, 45 (01) : 24 - 36
  • [14] Genetically determined intelligence and coronary artery disease risk
    Ling Li
    Shichao Pang
    Lingyao Zeng
    Ulrich Güldener
    Heribert Schunkert
    Clinical Research in Cardiology, 2021, 110 : 211 - 219
  • [15] Coronary Artery Disease in Patients with Ischemic Stroke and TIA
    Bhatia, Rohit
    Sharma, Gautam
    Patel, Chetan
    Garg, Ajay
    Roy, Ambuj
    Bali, Prerna
    Singh, Nishita
    Sisodia, Pranjal
    Sreenivas, Vishnubhatla
    Srivastava, M. V. Padma
    Prasad, Kameshwar
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (12):
  • [16] Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis
    Chen, Weiqi
    Wang, Shukun
    Lv, Wei
    Pan, Yuesong
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [17] Transient ischemic attack and coronary artery disease: a two-sample Mendelian randomization analysis
    Qi, Xiaoyi
    Wang, Shijia
    Qiu, Liangxian
    Chen, Xiongbiao
    Huang, Qianwen
    Ouyang, Kunfu
    Chen, Yanjun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [18] Stroke and Coronary Artery Disease
    Kovacik, M.
    Madarasz, S.
    Bartko, D.
    Pesta, M.
    Herzig, R.
    Kanovsky, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2010, 73 (05) : 497 - 502
  • [19] High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease
    Hisauchi, Itaru
    Ishikawa, Tetsuya
    Ayaori, Makoto
    Uto-Kondo, Harumi
    Koshikawa, Yuri
    Ukaji, Tomoaki
    Nakamura, Hidehiko
    Mizutani, Yukiko
    Taguchi, Isao
    Nakajima, Takatomo
    Mutoh, Makoto
    Ikewaki, Katsunori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (07) : 696 - 702
  • [20] Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men[S]
    Cahill, Leah E.
    Sacks, Frank M.
    Rimm, Eric B.
    Jensen, Majken K.
    JOURNAL OF LIPID RESEARCH, 2019, 60 (08) : 1457 - 1464